HEREDITARY HEMOCHROMATOSIS (HH) is a common autosomal recessive iron metabolism disorder, affecting nearly 1 in 200 -300 Caucasian adults (18, 25) . It is characterized by an excessive absorption of dietary iron resulting in increased body iron stores, which in turn can lead to organ dysfunction and failure, particularly of the liver, heart, and pancreas, and cause diseases such as hepatic fibrosis, cirrhosis, and hepatocellular carcinoma (26) .
HFE, the gene mutated in HH, is a major histocompatibility class-I gene (MHC-I). The most frequent cause of hemochromatosis is a point mutation resulting from a cysteine-to-tyrosine substitution at amino acid 282 (C282Y) of the human hemochromatosis protein (HFE) (10) . The C282Y mutation causes a decrease in cell surface expression and loss of interaction with ␤2-microglobulin (11) , reducing the affinity of HFE for the diferric transferrin receptor (16) and thus increased absorption of iron by the duodenal enterocyte. However, despite an increase in information about the structure and expression of HFE in the latest years, the exact mechanisms by which HFE regulates iron absorption are still not fully understood.
Hepcidin is now accepted as the major regulator of iron homeostasis, being downregulated in conditions of iron deficiency or increased erythropoiesis and upregulated in iron overload (23, 24) . In HFE-associated hemochromatosis, hepcidin expression is greatly diminished despite the elevated iron stores (6, 14) . In turn, bone morphogenetic protein 6 (BMP6), a key endogenous regulator for hepcidin (2, 19) , is also known to be impaired in a mouse model of hemochromatosis (8) .
Other biochemical abnormalities that characterize hemochromatosis can include increased serum transferrin saturation and serum ferritin and decreased total iron binding capacity (1) .
Among patients with HH, there is a male overrepresentation in terms of the number of patients diagnosed and also of the severity of iron overload (3, 4, 21, 27, 28) . This apparent sex difference in disease expression is usually attributed to iron loss during menstruation and pregnancy in women (28) . However, the literature is contradictory. In a cross sectional study of French and Canadian patients, Moirand et al. (21) found no difference between men and women with regard to age at presentation of clinical signs. In a later study, the same group found no difference in age, number of pregnancies, or menstruation between symptomatic and nonsymptomatic women homozygous for the mutated Hfe gene (22) . All these studies that evaluated the effect of sex on HH disease phenotype have used epidemiological approaches on the basis of a human population.
Using an animal model allows studies where key factors such as nutrition and reproductive experience can be controlled or experimentally manipulated. The Hfe knockout mouse model (HfeϪ/Ϫ) presents an iron overload phenotype similar to that observed in human patients, recapitulating key aspects of HH. In this study, we used wild-type and HfeϪ/Ϫ females to test whether multiple pregnancies would have an impact on iron stores.
MATERIALS AND METHODS
Animals. Animals generating data for the present study were part of an experiment studying mouse reproduction and maternal behavior. For the duration of the experiment, mice were fed ad libitum with a standard diet with an iron content of 312 mg/kg (8626 Teklad Mouse Breeder Diet; Teklad, Harlan, UK). The C57BL/6 (B6) and HfeϪ/Ϫ (backcrossed onto B6 background) female mice were bred and housed at the Instituto de Biologia Molecular e Celular (IBMC) animal facilities. One-year-old nulliparous and pluriparous (on average 29 weaned pups per female 11 wk after last delivery) B6 and HfeϪ/Ϫ female mice (n ϭ 6 -7) were euthanized (isoflurane anesthesia followed by cervical dislocation), and blood and tissues were collected. All animal experiments were carried out in compliance with the animal ethics guidelines at the institute and were approved by the Portuguese Veterinary Ethics Committee.
Hematological measurements. The blood samples were obtained by retro-orbital bleeding of nulliparous and pluriparous B6 and HfeϪ/Ϫ mice, under anesthesia. For the erythroid parameters, blood was collected in EDTA tubes, and hemoglobin, red blood cell counts, hematocrit, and mean corpuscular volume were assessed on a Coulter-S counter (Coulter Electronics, Fullerton, CA). For iron levels, 200 l of serum from each animal were used to determine the serum iron and total iron-binding capacity (TIBC) by the Liquid FerroZine method (Thermo Electron, Victoria, Australia) according to the manufacturer's instructions. Transferrin saturation was calculated as (serum iron/ TIBC) ϫ 100.
Serum ferritin measurements. Ferritin concentrations in the serum were determined by ELISA assays using polyclonal antibodies (Abs) raised against mouse recombinant L-ferritin subunits and calibrated with the corresponding recombinant homopolymer. The specificity and the absence of cross reactivity of the Abs have been previously described (29) . The microtiter plates were coated with polyclonal Abs specific for mouse L-ferritin. Serum samples or standard ferritins were diluted in 50 mM HEPES (Invitrogen, Carlsbad, CA) and 1% Igepal C-630 (Sigma-Aldrich, Sintra, Portugal) and added to the plates. The presence of ferritin was revealed by incubation with the same Ab labeled with biotin, followed by incubation with streptavidin (SigmaAldrich), and o-phenylenediamine dihydrochloride (Sigma-Aldrich) was used as colorimetric substrate.
Tissue nonheme iron measurements. Liver, spleen, heart, and pancreas samples from nulliparous and pluriparous B6 and HfeϪ/Ϫ mice were collected and stored at Ϫ80°C for further use. Tissue nonheme iron was measured by the bathophenanthroline method (30) . Briefly, tissue samples with an average weight of 100 mg were placed in iron-free Teflon vessels (ACV-Advanced Composite Vessel; CEM, Mathews, NC) and dried in a microwave oven (MDS 2000, CEM). Subsequently, dry tissue weights were determined and samples digested in an acid mixture (30% hydrochloric acid and 10% trichloroacetic acid) for 20 h at 65°C. After digestion, a chromogen reagent (5 volumes of deionized water, 5 volumes of saturated sodium acetate, and 1 volume of 0.1% bathophenanthroline sulfonate/1% thioglycolic acid) was added to the samples to react with iron and obtain a colored product that was measured spectrophotometrically at 535 nm. The extinction coefficient for bathophenanthroline is 22.14 mM/cm.
Hepcidin and BMP6 expression. Total RNA from livers was isolated with the RNeasy Midi Kit for Total RNA Isolation from Animal Cells (Qiagen, Valencia, CA) with the optional On-Column DNase Digestion with RNase-free DNase (Qiagen), and 1.25 g of total RNA were converted to cDNA by Thermoscript and an oligo (dT) 20 primer (Invitrogen), according to the manufacturer's instructions.
Relative levels of hepcidin 1, hepcidin 2, and BMP6 mRNAs were quantified by real-time RT-PCR analysis using an iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad, Hercules, CA). Primers used are as follows: GAPDH (housekeeping): mGAPDH forward, 5=-GCTGCCCAGAACATCATCCC-3= and mGAPDH reverse, 5=-ATGCCTGCTTCACCACCTTC-3=; hepcidin 1: mHepc1 forward, 5=-CCTATCTCCATCAACAGATG-3= and mHepc1 reverse, 5=-AACA-GATACCACACTGGGAA-3=; hepcidin 2: mHepc2 forward, 5=-CCTATCTCCATCAACAGATG-3= and mHepc2 reverse, 5=-AACAGATACCACAGGAGGGT-3=; BMP6: mBMP6 forward, 5=-TCCCCACATCAACGACACCA-3= and mBMP6 reverse, 5=-TCC-CCACCACACAGTCCTTG-3=. A second housekeeping gene [hypoxanthine-guanine phosphoribosyl transferase (HPRT): mHPRT forward, 5=-GTAATGATCAGTCAACGGGGGAC-3= and mHPRT reverse, 5=-CCAGCAAGCTTGCAACCTTAACCA-3=] was used to assure that any possible variations observed in the expression of genes of interest were not solely attributable to differences in GAPDH expression. One microliter of each cDNA sample was added to a reaction mix containing 10 l iQ SYBR Green Supermix (Bio-Rad), 8.5 l of ddH2O, and 250 nM of each primer, making a total volume of 20 l per reaction. Each sample was prepared in triplicate. A nontemplate control was included for each set of primers. The cycling profile was the following: 94°C for 3.5 min, 40 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 30 s. A melting curve was generated for every PCR product to confirm the specificity of the assays, and a dilution series was prepared to check the efficiency of the reactions. The comparative CT method (2 Ϫ⌬⌬CT method) based on CT values for hepcidin 1, hepcidin 2, BMP6, and GAPDH was used to analyze the expression levels of both hepcidins and BMP6.
Statistical analysis. Statistical analysis was carried out using SPSS for Windows, version 16 (SPSS Science, Chicago, IL). Value normality was checked by performing Kolmogorof-Smirnoff test, and Student's t-test was used for estimating statistical significance and comparing nulliparous and pluriparous females within each genotype. A P value Ͻ0.01 was considered statistically significant.
RESULTS
Hematological parameters. No significant differences were observed between nulliparous and pluriparous mice in either of the genotypes regarding serum iron, red blood cells, hemoglobin, and hematocrit (Table 1) . Pluriparous HfeϪ/Ϫ females presented significantly lower values of transferrin saturation and mean corpuscular volume than nulliparous females of the same genotype. In B6 pluriparous mice, increased levels of Values are represented as means Ϯ SD (n ϭ 6 -7), and differences were considered significant at *P Ͻ 0.01. B6, C57BL/6 mice; SI, serum iron (g/ml); TIBC, total iron-binding capacity (g/ml); Tf Sat, transferrin saturation (%); RBC, red blood cells (ϫ10 6 cells/l); HGB, hemoglobin (g/dl); HCT, hematocrit (%); MCV, mean corpuscular volume (fl).
TIBC were observed when compared with nulliparous females. The same was observed between HfeϪ/Ϫ nulliparous and pluriparous mice although the differences were not statistically significant.
Tissue iron. In both B6 and HfeϪ/Ϫ mice, iron concentration in the liver did not differ significantly between nulliparous and pluriparous females (Fig. 1) . However, when measuring total iron per organ, there was an overall trend for all measured organs (liver, spleen, heart, and pancreas) from pluriparous females to contain more iron than those of nulliparous females, both in the B6 and HfeϪ/Ϫ mice (Fig. 2, A and B ). Significant differences were observed for the spleen, heart, and pancreas in B6 mice and for the spleen and heart in HfeϪ/Ϫ mice. That trend becomes clearly evident when expressing the organ iron content as the sum of iron in the four organs. This total iron level is significantly higher in pluriparous females than in nulliparous females in both genotypes (Fig. 3) .
Serum ferritin. Levels of L-ferritin in the serum were measured by ELISA. No significant differences were observed between nulliparous and pluriparous females from both B6 and HfeϪ/Ϫ although there seems to be a tendency for increased levels in the pluriparous animals (Fig. 4) .
Hepcidin and BMP6 mRNA expression. Hepatic hepcidin 1 (Fig. 5A), hepcidin 2 (Fig. 5B) , and BMP6 (Fig. 5C ) mRNA expressions were measured by real-time PCR in nulliparous and pluriparous B6 and HfeϪ/Ϫ female mice. Lower expressions of hepcidin 1, hepcidin 2, and BMP6 were observed in the pluriparous females, when compared with the nulliparous, in both genotypes.
DISCUSSION
Reproductive iron loss is thought to underlie the observed reduction in disease expression in female HH carriers compared with men. In this study, we show experimental evidence that multiple pregnancies do not reduce body iron stores in a mouse model of hemochromatosis. In fact, most relevant clinical parameters of HH were either not significantly affected or even increased in pluriparous females compared with nulliparous females. n ϭ 6 -7) , and differences were considered significant at *P Ͻ 0.01. Fig. 3 . Combined iron stores (liver ϩ spleen ϩ heart ϩ pancreas) of nulliparous and pluriparous B6 and HfeϪ/Ϫ mice. Values are represented as means Ϯ SD (n ϭ 6 -7), and differences were considered significant at *P Ͻ 0.01. During normal development, the fetus has a high demand for iron, which is met from maternal sources. Iron is transferred from the maternal stores to the fetus, in amounts usually exceeding the normal maternal body iron stores. Consequently, an increase in iron absorption is required to provide the extra iron needed by the fetus and to replenish the maternal stores (20) .
It has also been argued that female iron loss in reproduction reduces the expression of HH (28) , in which case one would expect multiple pregnancies to result in a less severe disease phenotype. This assumption has been challenged by epidemiological data from humans (9) but has not previously been addressed experimentally. In the present experimental study of the HfeϪ/Ϫ mouse model of hemochromatosis, we show for the first time that multiple pregnancies do not reduce body iron stores in mice. To the contrary, there is an increase in tissue iron stores that is not only accounted for by the increased organ size in pluriparous females but also by an increased tissue iron concentration (both in B6 and HfeϪ/Ϫ). Also, with the exception of transferrin saturation, all relevant clinical parameters of HH were either not significantly affected or even increased in pluriparous females compared with nulliparous females, in both HfeϪ/Ϫ and in wild-type mice. Consequently, the iron overload phenotype of HfeϪ/Ϫ females remains largely unaffected by multiple pregnancies and subsequent lactations.
These results suggest that, despite abundant iron stores, female HfeϪ/Ϫ mice increase their iron uptake in response to the increased demands of pregnancy and lactation. This is corroborated by the observation of a reduced expression of hepcidin 1, hepcidin 2, and BMP6 in pluriparous females compared with nulliparous females.
Such a reduction in hepcidin expression is known to abrogate iron intestinal absorption inhibition (13) , and hepcidin has indeed been demonstrated to reach very low levels in pregnant rats, especially toward the end of pregnancy when the fetal iron demand is highest (20) . Whereas the role of hepcidin 1 in the regulation of iron metabolism in mice has been clearly demonstrated, the hepcidin 2 gene has been proposed to play a minor role (15, 17) . However, our results show that hepcidin 1 and hepcidin 2 respond in a similar fashion to the iron demands of pregnancy by a dramatic decrease in expression. This observation raises the question whether hepcidin 2 may have a more important function than previously thought, especially during pregnancy.
BMP6 has recently been demonstrated to be a key endogenous regulator of hepcidin, through the BMP/SMAD signaling pathway (2, 19) . BMP6 itself seems to be regulated by iron levels, but whether it is by circulating transferrin or hepatic iron is still unknown (7) . As such, a decrease in BMP6 expression is in accordance with the decrease in hepcidin expression. What is puzzling is the fact that, despite the high levels of iron in pluriparous females, BMP6 expression is nevertheless reduced.
The low hepatic hepcidin and BMP6 expressions of pluriparous females compared with nulliparous females, a mirror image of their tissue iron stores, may suggest an abrogation of iron intestinal absorption inhibition in response to pregnancy. Moreover, the fact that these results were observed both in iron overload in HfeϪ/Ϫ and wild-type mice indicate that iron absorption during pregnancy is regulated on a level that is independent of iron stores presently available in the female body, as previously shown in experimentally iron overloaded and deficient mice (5) . Reinforcing this assumption is the fact that recently, Gambling et al. (12) proposed that, at a certain point of pregnancy, maternal hepcidin levels are modulated, not by maternal iron levels, but rather by fetal iron levels.
In conclusion, multiple pregnancies do not alleviate the disease phenotype of HfeϪ/Ϫ mice, an animal model of HH. In addition, the decreased hepcidin and BMP6 expression response to multiple pregnancies in both iron overloaded HfeϪ/Ϫ and normal wild-type mice suggests that mechanisms regulating iron metabolism during pregnancy are independent of the iron status in hemochromatosis carriers. , and BMP6 (C) expressions were assessed by real-time PCR in the liver of nulliparous and pluriparous B6 and HfeϪ/Ϫ mice. GAPDH was used as the housekeeping gene. Values are represented as means Ϯ SD (n ϭ 6 -7), and differences were considered significant at *P Ͻ 0.01.
However, a good deal of caution is needed when trying to extrapolate this data to humans because there are several physiological and behavioral differences between humans and mice that are not represented in the HfeϪ/Ϫ mouse model, the most marked being the fact that mice do not menstruate, and as such iron loss during menstruation was not mimicked in this study.
Nevertheless, these results challenge the view that pregnancyassociated iron loss explains sex differences in the expression of HH, suggesting that other possibilities should be considered to explain the differences between males and females in the regulation of iron metabolism.
